Visual Abstract

Aims: Endogenous insulin secretion may increase in type 1 diabetes pregnancy. We assessed longitudinal patterns of maternal C-peptide concentration to investigate potential mechanisms.

Methods: Highly-sensitive direct and solid-phase competitive electrochemiluminescent immunoassays measured C-peptide in maternal serum (12, 24, 34 wks; n127) and cord blood (n85) from the continuous glucose monitoring in type 1 diabetes pregnancy trial (CONCEPTT).

Results: Three discrete patterns of maternal C-peptide trajectory were identified (Figure1): Pattern 1 undetectable throughout pregnancy (Figure1a; n74; 58%); Pattern 2 detectable at baseline (Figure1b; n22; 17%); Pattern 3 undetectable C-peptide (12 and 24wks), became detectable at 34 wks (Figure1b; n31; 24%). Offspring of women in pattern 3 had higher rates of neonatal hypoglycemia (42% vs. 14%; p=0.001), large-for-gestational-age (Figure1c; 90% vs. 60%; p=0.002) and elevated cord blood C-peptide (Figure 1d; geometric mean 1319 vs. 718 pmol/l; p=0.007) compared to offspring from women in pattern 1, despite comparable 34-week glycemia.

Conclusion: Increased C-peptide in maternal serum at 34 weeks suggests fetal hyperinsulinism with fetal-to-maternal transfer not improved maternal beta cell function. First appearance of C peptide in late pregnancy could identify pregnancies at highest risk of neonatal complications.

Disclosure

C. L. Meek: None. R. A. Oram: Consultant; Self; Janssen Research & Development, LLC. T. J. Mcdonald: None. D. Feig: Advisory Panel; Self; Novo Nordisk. A. T. Hattersley: None. H. R. Murphy: None.

Funding

JDRF (17/2011/533, 80/2010/585); Medtronic; Diabetes UK (17/0005712, 16/0005529); European Foundation for the Study of Diabetes; Novo Nordisk Foundation (NNF19SA058974); National Institute for Health Research (CDF-2013-06-035); UK Wellcome Trust; Tommy’s

Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at http://www.diabetesjournals.org/content/license.